Intravenous nicorandil did not significantly reduce primary composite outcomes in patients with STEMI
Trial shows intravenous nicorandil does not improve heart attack outcomes
This randomized controlled trial of 1,503 patients with STEMI found no significant difference in the primary composite outcome between intra…
A large trial of over 1,500 patients found that the drug nicorandil did not improve primary outcomes for those with a heart attack.
Functional Coronary Angiography Improves Clinical Outcomes in Multivessel STEMI Patients
Physiology guided heart procedures show lower risk of major events
Physiology-guided revascularization significantly reduces major adverse cardiac events and improves safety profiles compared to traditional …
A large international trial shows that using functional imaging to guide heart artery procedures may lower the risk of stroke and heart atta…
Ticagrelor monotherapy following primary PCI for STEMI shows reduced non-access site bleeding
Trial shows ticagrelor monotherapy may reduce bleeding after heart attack
This pilot study compared ticagrelor monotherapy against ticagrelor plus aspirin in patients with STEMI after primary PCI. The trial reporte…
A pilot study suggests that using ticagrelor alone after a heart attack may reduce specific types of bleeding compared to a dual-drug approa…
High-dose statin preloading increases TIMI flow grade 3 and reduces all-cause mortality in STEMI
High dose statins may improve outcomes for heart attack patients
This meta-analysis of 1862 patients with STEMI undergoing primary PCI indicates that high-dose statin preloading is associated with improved…
A high dose of statins before a heart procedure may improve blood flow and lower death rates for patients with a heart attack.
Pressure optimization protocol improves reperfusion success and reduces postdilation in STEMI patients
New stenting technique improves blood flow after heart attacks
This multicenter randomized trial of 607 patients undergoing primary PCI for STEMI found that a pressure optimization protocol (POP) signifi…
A new pressure optimization method during heart surgery helps restore blood flow faster and reduces the need for extra procedures.
Adjunctive intracoronary thrombolysis reduces major adverse cardiovascular events in patients with STEMI
Intracoronary Thrombolysis Linked to Lower Risks After Heart Attack
This meta-analysis evaluated the impact of adjunctive intracoronary thrombolysis during primary percutaneous coronary intervention for patie…
Adding intracoronary thrombolysis during heart procedures may lower the risk of major complications and improve blood flow for patients with…
Persistent microvascular obstruction predicts higher MACE and death risks following ST-segment elevation myocardial infarction
Persistent heart muscle damage after heart attack increases risk
This meta-analysis of 2180 patients with STEMI identifies persistent microvascular obstruction as a significant prognostic indicator. Persis…
Patients with lasting microvascular obstruction after a heart attack face higher risks of death and major complications compared to those wi…
Intracoronary mesenchymal stem cell administration improves left ventricular ejection fraction following ST-segment elevation myocardial infarction
Stem cells improve heart function after heart attack but not outcomes
This meta-analysis of 8 randomized controlled trials found that intracoronary mesenchymal stem cell (MSC) administration significantly impro…
New data shows stem cell treatment improves heart muscle pumping power after a heart attack, though it does not yet reduce hospital visits o…
Ticagrelor reduces mortality and major adverse cardiovascular events compared to clopidogrel in STEMI patients
Ticagrelor Shows Lower Mortality Risk Than Clopidogrel for Heart Patients
This meta-analysis of 31,729 adult STEMI patients post-PCI found that ticagrelor significantly reduced all-cause mortality (OR = 0.64) and m…
A large analysis of over 31,000 patients suggests ticagrelor may lower mortality and heart attack risks compared to clopidogrel after a hear…
Transvalvular microaxial flow pump plus PCI does not reduce infarct size in anterior STEMI
Trial shows microaxial flow pump does not reduce heart damage
This randomized controlled trial of 527 adults with acute anterior STEMI found that LV unloading with a transvalvular microaxial flow pump f…
A clinical trial found that using a transvalvular microaxial flow pump before heart surgery did not reduce the size of heart tissue damage.
Staged revascularization shows no significant difference versus immediate revascularization for major adverse cardiovascular events in STEMI and MVD patients
Timing of heart surgery does not change survival for a specific heart attack group
This meta-analysis reviewed 5077 patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease comparing …
A large review found that waiting for staged heart surgery did not improve survival or reduce heart attacks compared to immediate surgery fo…
Prehospital unfractionated heparin bolus improved TIMI flow in STEMI without increasing bleeding risk
Pretreatment with UFH improves artery flow for STEMI patients without extra bleeding risk
This single-center randomized trial evaluated pretreatment with unfractionated heparin in patients with ST-segment-elevation myocardial infa…
Giving unfractionated heparin early at first medical contact improved artery flow in heart attack patients without increasing bleeding risk.
Research across Myocardial ischemia
Related studies from across the Myocardial ischemia family.
Impella CP improves survival in selected cardiogenic shock patients while routine early VA-ECMO lacks clear benefit
New data clarifies the role of heart pumps in shock
This narrative review examines the use of VA-ECMO and microaxial-pump strategies in patients with cardiogenic shock and ST-elevation myocard…
New research looks at how heart pumps and bypass machines help patients with severe heart damage after a heart attack.
Individualized mechanical circulatory support is necessary as increased hemodynamic support does not uniformly improve survival
Mechanical Support for Cardiogenic Shock Does Not Uniformly Improve Survival
This mini review examines the role of short-term mechanical circulatory support (MCS) in patients with cardiogenic shock, including those wi…
Newer reviews suggest that while mechanical support helps heart function, it does not always lead to better survival rates for patients in c…
Qili Qiangxin plus conventional medicine improves surrogate markers in heart failure after myocardial infarction
Qili Qiangxin May Improve Heart Function After Heart Attack
This meta-analysis of 1391 patients found that Qili Qiangxin combined with conventional Western medicine led to greater reductions in NT-pro…
Adding Qili Qiangxin to standard medicine may improve heart function and quality of life for patients following a heart attack.
OMI/NOMI approach increases immediate invasive management to 45.4% compared to 13.6% in myocardial infarction
New approach helps doctors find blocked heart arteries more quickly during emergencies
This multicenter randomized controlled trial substudy evaluated 4398 adult patients with myocardial infarction to compare the OMI/NOMI appro…
A new way of looking at heart attacks helps doctors find blocked arteries faster, leading to quicker treatment for patients in need.
NLRP3 inflammasome activation serves as a molecular bridge between myocardial infarction and depression
Inflammasome Activation Links Heart Attacks and Depression
This systematic review examines the role of the NLRP3 inflammasome in the link between myocardial infarction and depression. The authors con…
A specific inflammatory pathway called NLRP3 may act as a bridge between heart attacks and depression, potentially offering a new target for…
Beta-blocker therapy shows no significant reduction in primary composite outcomes for patients with LVEF ≥ 40%
Beta-blocker therapy shows mixed results for heart attack patients
This meta-analysis of 18,504 patients with acute myocardial infarction and LVEF ≥ 40% found no significant reduction in the primary composit…
New data suggests beta-blockers may only show a significant benefit for heart attack patients with specific levels of heart muscle function.
Beta-blocker outcomes vary by myocardial infarction type and left ventricular ejection fraction
Trial shows different heart medication effects based on heart attack type
This prespecified subgroup analysis examined the impact of beta-blockers on primary outcomes in patients with STEMI and NSTEMI. The findings…
New data suggests that beta-blockers may have different impacts on patients depending on the specific type of heart attack they experience.
Naoxintong Supplementation Reduces Heart Failure Risk Following Acute Myocardial Infarction
New treatment may lower heart failure risk after heart attack
A randomized trial suggests that adding Naoxintong to standard therapy significantly reduces heart failure incidence and MACE rates post-AMI…
A new study shows that adding a herbal formula to standard care can significantly reduce heart failure risk for patients after a heart attac…
Clinical signs, imaging, and biomarkers facilitate risk stratification for cardiac rupture in myocardial infarction
New tools help doctors predict life-threatening heart ruptures after heart attacks
This mini review synthesizes clinical warning signs, point-of-care imaging, and biomarker trajectories to stratify risk of cardiac rupture i…
Doctors are developing a new four-step plan to spot early warning signs of heart rupture, a condition where the heart muscle tears during a …
DeepSeek AI generates guideline-conforming exercise prescriptions for myocardial infarction, heart failure, and atrial fibrillation
AI Shows Potential for Creating Heart Health Exercise Plans
This guideline-based simulation study evaluates the use of the DeepSeek model to generate exercise prescriptions for patients with myocardia…
A simulation study shows that AI can generate safe, guideline-based exercise plans for patients with heart conditions like heart failure and…
High-intensity statin adherence correlates with greater LDL-C reductions and improved plaque stability post-AMI
High-Intensity Statins Show Better Results for Heart Patients Following Heart Attack
This randomized controlled trial sub-study of 255 patients with acute myocardial infarction evaluated high-intensity statin therapy. Adheren…
Patients who strictly followed their high-intensity statin regimen after a heart attack showed significantly better improvements in heart he…
GLP-1 receptor agonists reduce MACE (HR 0.69) and all-cause mortality (HR 0.67) in Type 2 Diabetes
GLP-1 medications show promise for heart health in diabetes
This meta-analysis of 37,393 patients with Type 2 Diabetes and myocardial infarction-defined populations found that GLP-1 receptor agonists …
A large review of over 37,000 patients suggests GLP-1 medications may lower heart failure risks for those with Type 2 Diabetes.
Questions about ST-Segment Elevation Myocardial Infarction
Are many current STEMI treatment guidelines based on strong scientific evidence?
No, many current STEMI treatment guidelines are based on moderate or low-quality evidence, with only a small fraction supported by high-level studies.
Full answer →Can a CT scan show hidden lung water that predicts bad outcomes in STEMI?
Yes, a CT scan can detect hidden lung water (extravascular lung water) in STEMI patients, and this finding is linked to a higher risk of in-hospital major adverse cardiovascular events.
Full answer →How accurate is the new model for predicting heart failure after STEMI surgery?
A new model predicts acute heart failure after STEMI PCI with 82.4% accuracy, 74% sensitivity, and 86.8% specificity, outperforming older scores.
Full answer →Does the timing of my heart surgery affect how well blood flows in STEMI?
Yes, timing matters: longer delays from symptom onset to PCI are linked to worse blood flow and outcomes in STEMI.
Full answer →Can taking nicorandil during heart surgery improve blood flow for STEMI patients?
Yes, a 2024 trial found that giving intracoronary nicorandil during primary PCI improves blood flow (TIMI grade) and reduces microvascular resistance in STEMI patients.
Full answer →All ST-Segment Elevation Myocardial Infarction Articles
- Intravenous nicorandil did not significantly reduce primary composite outcomes in patients with STEMI
- Functional Coronary Angiography Improves Clinical Outcomes in Multivessel STEMI Patients
- Ticagrelor monotherapy following primary PCI for STEMI shows reduced non-access site bleeding
- High-dose statin preloading increases TIMI flow grade 3 and reduces all-cause mortality in STEMI
- Pressure optimization protocol improves reperfusion success and reduces postdilation in STEMI patients
- Adjunctive intracoronary thrombolysis reduces major adverse cardiovascular events in patients with STEMI
- Persistent microvascular obstruction predicts higher MACE and death risks following ST-segment elevation myocardial infarction
- Intracoronary mesenchymal stem cell administration improves left ventricular ejection fraction following ST-segment elevation myocardial infarction
- Ticagrelor reduces mortality and major adverse cardiovascular events compared to clopidogrel in STEMI patients
- Transvalvular microaxial flow pump plus PCI does not reduce infarct size in anterior STEMI
- Staged revascularization shows no significant difference versus immediate revascularization for major adverse cardiovascular events in STEMI and MVD patients
- Prehospital unfractionated heparin bolus improved TIMI flow in STEMI without increasing bleeding risk
- Intracoronary nicorandil improves TIMI flow and reduces AMR in STEMI patients undergoing primary PCI
- Atorvastatin dose and PCI timing predict hypoperfusion in STEMI patients
- Predictive model for acute heart failure in STEMI patients after PCI shows high accuracy
- Residual global μQFR assessment associated with 3-year MACE risk in acute coronary syndrome patients
- CT-detected subclinical pulmonary congestion associated with in-hospital MACE in Killip class 1 STEMI
- STEMI guidelines rely heavily on moderate and low-quality evidence, meta-analysis finds
- Retrospective study identifies five predictors for hypokalemia in STEMI patients
- Phase 2 trial tests pre-hospital glucocorticoid pulse in STEMI patients undergoing primary PCI
- Immediate revascularization tied to higher 1-year risk in STEMI with multivessel disease and heart failure